Author's Reply

1. Adra M , Lawrence KR . Trimethoprim/sulfamethoxazole for treatment of severe Staphylococcus aureus infections. Ann Pharmacother 2004; 38: 338–41. DOI 10.1345/aph.1D156

2. Centers for Disease Control and Prevention. Brief report: vancomycin-resistant Staphylococcus aureus—New York, 2004. MMWR Morb Mortal Wkly Rep 2004; 53: 322–3.

3. Infectious Diseases Society of America. Bad bugs, no drugs. As antibiotic discovery stagnates…a public health crisis brews. www.idsociety.org/Template.cfm?Section=Home&Template=/ContentManagement/ContentDisplay.cfm&ContentID=10015 (accessed 2004 Aug 19).

4. Wenzel RP . The antibiotic pipeline—challenges, costs, and values. N Engl J Med 2004; 351: 523–6.

5. Spellberg B , Powers JH , Brass EP , Miller LG , Edwards JE Jr . Trends in antimicrobial drug development: implications for the future. Clin Infect Dis 2004; 38: 1279–86.